Form D · Biotechnology
Sentire Medical Systems, Inc.
Palm Beach Gardens, FL · CIK 0001728443
Offering snapshot reported Feb 4, 2026 · SEC filing
- Reported sold
- $1.17M Offering amount: $1.2M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Dec 15, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 4, 2026 | Initial | $1,167,544 | No comparison | 9 | SEC filing |
| Jan 19, 2018 | Initial | $600,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-572419
Source: Form D, filed Feb 4, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Peng Cheng | Director |
| Jonathan Diamond | Director |
| David Krasne | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10455 Riverside Drive Suite 110
Palm Beach Gardens, FL, 33410
Palm Beach Gardens, FL, 33410